Lineage Cell Therapeutics (LCTX) Earnings Date, Estimates & Call Transcripts → The best trading strategy for markets right now (From DTI) (Ad) Free LCTX Stock Alerts $0.91 -0.01 (-0.84%) (As of 10:13 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Earnings SummaryLatest Earnings DateMay. 9EstimatedActual EPS (May. 9) -$0.04 Consensus EPS (May. 9) -$0.04 Read Call TranscriptListen to Call Get Lineage Cell Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for LCTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLCTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LCTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! Lineage Cell Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.12) EPSNext Year EPS Consensus Estimate: ($0.12) EPSLCTX Earnings Date and InformationLineage Cell Therapeutics last posted its earnings results on May 9th, 2024. The reported ($0.04) earnings per share for the quarter, hitting the consensus estimate of ($0.04). The company earned $1.44 million during the quarter, compared to analysts' expectations of $2.22 million. Lineage Cell Therapeutics has generated ($0.14) earnings per share over the last year (($0.14) diluted earnings per share). Earnings for Lineage Cell Therapeutics are expected to remain at ($0.12) per share in the coming year. Read More Lineage Cell Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript5/9/2024Q1 2024($0.04)($0.04)-($0.04)$2.22 million$1.44 million 3/7/2024Q4 2023($0.07)($0.03)+$0.04($0.03)$4.74 million$2.09 million11/9/2023Q3 2023($0.04)($0.04)-($0.04)$3.30 million$1.25 million8/10/2023Q2 2023($0.04)($0.03)+$0.01($0.03)$2.65 million$3.23 million 5/11/2023Q1 2023($0.03)($0.03)-($0.03)$3.04 million$2.39 million3/9/2023Q4 2022($0.03)($0.03)-($0.03)$2.97 million$1.92 million Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022($0.03)($0.04)($0.01)($0.04)$4.11 million$3.00 million8/11/2022Q2 2022($0.03)($0.04)($0.01)($0.04)$4.86 million$4.55 million5/12/2022Q1 2022$0.01($0.04)($0.05)($0.04)$12.07 million$5.24 million3/10/2022Q4 2021($0.04)($0.05)($0.01)$0.07$1.20 million$1.20 million 11/10/2021Q3 2021($0.05)($0.05)-($0.05)$0.56 million$2.27 million 8/12/2021Q2 2021($0.03)($0.03)-($0.03)$1.05 million$0.51 million 5/13/2021Q1 2021($0.04)($0.01)+$0.03($0.11)$1.07 million$0.39 million 3/10/2021Q4 2020($0.05)$0.01+$0.06$0.01$1.34 million$0.36 million 11/4/2020Q3 2020($0.05)($0.04)+$0.01($0.03)$0.65 million$0.57 million11/4/2020Q3 2020($0.05)($0.04)+$0.01($0.03)$0.65 million$0.57 million11/4/2020Q3 2020($0.05)($0.05)-($0.03)$0.65 million$0.57 million 8/6/2020Q2 2020($0.04)($0.04)-($0.04)$0.76 million$0.39 million8/6/2020Q2 2020($0.04)($0.04)-($0.04)$0.76 million$0.39 million8/6/2020Q2 2020($0.04)($0.04)-($0.04)$0.76 million$0.39 million 5/7/2020Q1 2020($0.05)($0.06)($0.01)($0.06)$0.93 million$0.51 million5/7/2020Q1 2020($0.05)($0.06)($0.01)($0.06)$0.93 million$0.51 million5/7/2020Q1 2020($0.05)($0.06)($0.01)($0.06)$0.93 million$0.51 million 3/12/2020Q4 2019($0.07)($0.03)+$0.04($0.03)$0.60 million$1.24 million3/12/2020Q4 2019($0.07)($0.03)+$0.04($0.03)$0.60 million$1.24 million 3/12/2020Q4 2019($0.07)($0.03)+$0.04($0.03)$0.60 million$1.24 million 11/12/2019Q3 2019($0.05)($0.04)+$0.01$0.03$0.94 million$0.57 million11/12/2019Q3 2019($0.05)($0.04)+$0.01$0.03$0.94 million$0.57 million11/12/2019Q3 2019($0.05)($0.04)+$0.01$0.03$0.94 million$0.57 million8/8/2019Q2 2019($0.05)($0.06)($0.01)$0.08$1.04 million$0.78 million8/8/2019Q2 2019($0.05)($0.06)($0.01)$0.08$1.04 million$0.78 million8/8/2019Q2 2019($0.05)($0.06)($0.01)$0.08$1.04 million$0.78 million Lineage Cell Therapeutics Earnings - Frequently Asked Questions When did Lineage Cell Therapeutics announce their last quarterly earnings? Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) last announced its quarterly earning data on Thursday, May 9, 2024. Learn more on LCTX's earnings history. Did Lineage Cell Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) reported ($0.04) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.04). Learn more on analysts' earnings estimate vs. LCTX's actual earnings. How can I listen to Lineage Cell Therapeutics's earnings conference call? The conference call for Lineage Cell Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Lineage Cell Therapeutics's conference call transcript? The conference call transcript for Lineage Cell Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Lineage Cell Therapeutics generate each year? Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded annual revenue of $8.94 million. How much profit does Lineage Cell Therapeutics generate each year? Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded net income of -$21.49 million. LCTX has generated -$0.14 earnings per share over the last four quarters. What is Lineage Cell Therapeutics's EPS forecast for next year? Lineage Cell Therapeutics's earnings are expected to stay at ($0.12) per share in the next year. More Earnings Resources from MarketBeat Related Companies: TSHA Earnings CRGX Earnings RGNX Earnings EXAI Earnings ITOS Earnings LXEO Earnings VALN Earnings KYTX Earnings PROK Earnings REPL Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NYSEAMERICAN:LCTX) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored"Trump Loophole" Beats InflationThe demise of the "petrodollar" appears imminent. And the implications for Americans could be dire.Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.